Green Cross Wellbeing
Clinical trials sponsored by Green Cross Wellbeing, explained in plain language.
-
Placenta extract shows promise for liver disease in early trial
Disease control CompletedThis study tested a medicine called LAENNEC, made from human placenta, in 49 adults with chronic liver disease (from alcohol or fatty liver). The goal was to check safety and find the best dose by measuring liver enzyme (ALT) levels. It was a Phase 2 trial, meaning it's an early …
Phase: PHASE2 • Sponsor: Green Cross Wellbeing • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Immune booster supplement shows promise in new study
Disease control CompletedThis study tested whether a supplement called GCWB1176 can improve immune function in adults aged 19 to 75 with normal or slightly low white blood cell counts. 100 participants took either the supplement or a placebo for 8 weeks. Researchers measured changes in natural killer (NK…
Phase: NA • Sponsor: Green Cross Wellbeing • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Placenta injection eases shoulder pain?
Symptom relief CompletedThis study tested if an injection made from human placenta, called LAENNEC, can reduce shoulder pain in people with shoulder impingement syndrome. 50 adults with shoulder pain received either the LAENNEC injection or a placebo. The main goal was to see if pain levels improved.
Phase: NA • Sponsor: Green Cross Wellbeing • Aim: Symptom relief
Last updated May 17, 2026 10:10 UTC
-
New supplement tested for easing cough and chest discomfort
Symptom relief CompletedThis study tested a supplement called GCWB1001 in 120 adults with mild breathing symptoms like cough, phlegm, and chest tightness. Participants took the supplement or a placebo for 12 weeks to see if it improved symptoms and lung function. The goal was to find a safe way to ease …
Phase: NA • Sponsor: Green Cross Wellbeing • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC